PARK THERAPEUTICS
Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of pain which is Phase III-ready. Development focused biotechnology company, whose goal is finding better solutions for pain patients.
PARK THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2020-01-01
Address:
Morristown, New Jersey, United States
Country:
United States
Website Url:
http://www.parktherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Wix
Official Site Inspections
http://www.parktherapeutics.com
- Host name: 81.224.148.132.host.secureserver.net
- IP address: 132.148.224.81
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Park Therapeutics"
Park Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Park Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news.See details»
Park Therapeutics - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... www.parktherapeutics.com. …See details»
Tris Pharma® Announces Acquisition of Park Therapeutics - Pain …
Apr 29, 2021 Tris Pharma® Announces Acquisition of Park Therapeutics - Pain Company with First-In-Class, Phase III-Ready New Chemical Entity (NCE) - Novel mechanism of action, …See details»
Park Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Park Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Park Therapeutics Company Profile 2024: Valuation, Investors ...
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-11285113-B2: Room temperature stable oral calcitonin formulation: ActiveSee details»
Tris Pharma® Announces Acquisition of Park Therapeutics
Apr 29, 2021 Tris Pharma is a New Jersey-based specialty pharmaceutical company focused on the development and commercialization of innovative medicines that address unmet patient …See details»
Tris Pharma acquires Park Therapeutics - 2021-04-29 - Crunchbase
Apr 29, 2021 Acquired Organization: Park Therapeutics Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of pain which is …See details»
Park Therapeutics - Ownership and Business Overview | Mergr
Apr 29, 2021 Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021.The largest life science acquisition in 2021 was Pharmaceutical Product Development …See details»
CEO and Executive Team - The Org
About. Park Therapeutics' CEO and Executive Team includes James Hackworth.See details»
Park Therapeutics - Products, Competitors, Financials, Employees ...
Flying Under the Radar, Tris Pharma Builds Strong Pipeline in ADHD, Pain, Neurological Disorders. May 16, 2023. By Alex Keown May 16, 2023 In the continual wake of the opioid …See details»
Ketan Mehta - Board Member at Park Therapeutics | The Org
Mr. Mehta is the founder and CEO of Tris Pharma, a specialty pharmaceutical company. Under his leadership, Tris has developed many innovative formulation technologies, launched new …See details»
Park Therapeutics (LKW7MCDM3GG5) - HigherGov
Park Therapeutics (UEI LKW7MCDM3GG5, CAGE 8TKS5) based in Monmouth Junction NJ federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Tris Pharma® Acquires Park Therapeutics | American …
Apr 29, 2021 Tris Pharma, Inc., a specialty pharmaceutical company with a portfolio of approved products and a late-stage pipeline of product candidates for the treatment of Attention Deficit …See details»
The latest R&D info about Park Therapeutics, Inc.: pipelines, …
May 6, 2023 A randomized, double blind, four-period, six-treatment, double-dummy, placebo controlled, partial-crossover study to explore and compare the ventilatory response to …See details»
Innovative Solutions for ADHD, Pain & CNS Disorders | Tris Pharma
Oct 1, 2024 "At Tris Pharma, our mission is to uniquely solve some of the most intractable therapeutic challenges in ADHD, pain, addiction and diseases of the central nervous system …See details»
Park Therapeutics, Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Parktherapeutics Web Analysis - Parktherapeutics.com
Parktherapeutics.com is 4 years 3 months old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats …See details»
Therapeutic areas | GSK Canada
To get ahead of disease, we prioritize research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the …See details»
PaRx: A Prescription for Nature
2 hours a week, 20+ minutes each time. That’s all it takes. We’re breaking ground as Canada’s first national, evidence-based nature prescription program.See details»